NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 70069-0191-01 — Pilocarpine 2% eye dropsAI (563 hospitals, 40,051–41,230 samples)
• NDC 43598-0210-55 — Silver sulfadiazine 1% creamAI (561 hospitals, 40,128–41,208 samples)
• NDC 00781-7135-93 — Moxifloxacin 0.5% eye dropsAI (405 hospitals, 39,899–41,069 samples)
• NDC 63323-0806-20 — Fentanyl injection, 50 mcg per mLAI (367 hospitals, 33,658–40,993 samples)
• NDC 67877-0124-05 — Silver sulfadiazine 1% creamAI (518 hospitals, 39,715–40,984 samples)
• NDC 70092-1153-46 — Lidocaine numbing injection syringe, 10 mLAI (58 hospitals, 40,958 samples)
• NDC 65219-0470-05 — Sodium chloride 0.9% intravenous bolus solutionAI (162 hospitals, 34,441–40,948 samples)
• NDC 00832-0465-15 — Nystatin powder for topical useAI (528 hospitals, 39,545–40,940 samples)
• NDC 00574-4024-35 — Erythromycin eye ointmentAI (432 hospitals, 39,457–40,870 samples)
• NDC 70436-0126-82 — Low-osmolar iodine contrast dye, per milliliterAI (44 hospitals, 40,531–40,783 samples)
• NDC 24201-0100-01 — Acetaminophen (Tylenol) intravenous solutionAI (486 hospitals, 40,147–40,669 samples)
• NDC 63323-0172-60 — Carboplatin chemotherapy IV solutionAI (413 hospitals, 40,376–40,664 samples)
• NDC 63323-0113-10 — Pentamidine 300 mg injection vialAI (761 hospitals, 38,857–40,648 samples)
• NDC 63323-0485-41 — Lidocaine 1% injection solutionAI (147 hospitals, 37,377–40,608 samples)
• NDC 61314-0628-10 — Polymyxin B and trimethoprim eye dropsAI (945 hospitals, 39,357–40,599 samples)
• NDC 70100-0424-01 — Indocyanine green injectionAI (468 hospitals, 39,967–40,597 samples)
• NDC 81483-0037-00 — Lidocaine with epinephrine injectionAI (121 hospitals, 39,598–40,597 samples)
• NDC 59651-0214-30 — Azelastine nasal sprayAI (452 hospitals, 39,497–40,586 samples)
• NDC 00378-9102-93 — Nitroglycerin 24-hour skin patch, 0.1 mg per hourAI (690 hospitals, 39,270–40,539 samples)
• NDC 61314-0631-36 — Neomycin, polymyxin and dexamethasone eye ointmentAI (816 hospitals, 39,282–40,515 samples)
• NDC 24208-0485-10 — Dorzolamide 2% eye dropsAI (874 hospitals, 39,231–40,500 samples)
• NDC 61314-0143-05 — Brimonidine tartrate 0.2% eye dropsAI (844 hospitals, 39,107–40,493 samples)
• NDC 67877-0124-50 — Silver sulfadiazine 1% cream for topical useAI (641 hospitals, 39,313–40,492 samples)
• NDC 45802-0064-35 — Triamcinolone acetonide 0.1% topical creamAI (846 hospitals, 39,222–40,437 samples)
• NDC 50383-0232-10 — DORZOLAMIDE 2 % EYE DROPSAI (322 hospitals, 39,395–40,403 samples)
• NDC 60758-0801-05 — Timolol eye drops 0.5%AI (659 hospitals, 39,217–40,360 samples)
• NDC 00781-6186-67 — Ciprofloxacin and dexamethasone ear dropsAI (511 hospitals, 38,608–40,336 samples)
• NDC 25021-0701-02 — Ketorolac 60 mg/2 mL injectionAI (160 hospitals, 37,531–40,330 samples)
• NDC 00338-0023-03 — Dextrose 10% in water IV solutionAI (584 hospitals, 38,814–40,317 samples)
• NDC 00009-0039-30 — Methylprednisolone sodium succinate injection 40 mgAI (700 hospitals, 19,470–40,305 samples)
• NDC 00019-1323-90 — Iohexol 320 contrast injection syringeAI (52 hospitals, 39,371–40,280 samples)
• NDC 45802-0059-11 — Nystatin 100,000 unit/g topical creamAI (516 hospitals, 39,040–40,255 samples)
• NDC 62332-0600-01 — Ketorolac 30 mg/mL injectionAI (235 hospitals, 36,369–40,248 samples)
• NDC 50383-0775-17 — Lidocaine viscous oral solution, 15 mL cupAI (412 hospitals, 39,036–40,242 samples)
• NDC 00409-0182-25 — Gemcitabine 2 gram intravenous solutionAI (118 hospitals, 40,122–40,221 samples)
• NDC 64980-0514-05 — Timolol eye drops 0.5%AI (671 hospitals, 39,033–40,212 samples)
• NDC 43598-0265-20 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (108 hospitals, 38,495–40,169 samples)
• NDC 63323-0269-94 — Diprivan (propofol) 200 mg IV anesthesia injectionAI (326 hospitals, 33,623–40,157 samples)
• NDC 45802-0953-01 — Diclofenac sodium 1% topical gelAI (592 hospitals, 38,915–40,148 samples)
• NDC 68382-0370-01 — Nystatin 100,000 unit/g topical powderAI (329 hospitals, 38,929–40,126 samples)
• NDC 68462-0180-22 — Mupirocin 2% ointment for topical useAI (900 hospitals, 38,476–40,078 samples)
• NDC 63323-0495-04 — Lidocaine 2% injection, preservative-freeAI (459 hospitals, 34,374–40,062 samples)
• NDC 00116-2001-16 — Chlorhexidine 0.12% mouthwashAI (587 hospitals, 38,831–40,037 samples)
• NDC 00713-0678-31 — Nystatin 100,000 units per gram topical creamAI (289 hospitals, 38,804–40,010 samples)
• NDC 63323-0103-51 — Cisplatin 1 mg/mL solution, 50 mL vialAI (662 hospitals, 39,525–39,957 samples)
• NDC 59762-0333-02 — Latanoprost 0.005% eye dropsAI (821 hospitals, 38,623–39,883 samples)
• NDC 00409-2305-05 — Midazolam injection, 5 mg per 5 mLAI (693 hospitals, 32,725–39,871 samples)
• NDC 00409-6625-02 — Sodium bicarbonate 8.4% intravenous solutionAI (307 hospitals, 36,274–39,856 samples)
• NDC 61570-0131-55 — Silvadene 1% topical creamAI (433 hospitals, 38,585–39,854 samples)
• NDC 62332-0505-03 — Moxifloxacin eye dropsAI (367 hospitals, 38,739–39,846 samples)